Long-Term Cost Effectiveness Analysis Of Ideglira Versus Glp-1 Added To Basal Insulin As Intensification Therapies In Type 2 Diabetes Mellitus In Spain
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1714
https://www.valueinhealthjournal.com/article/S1098-3015(16)01782-4/fulltext
Title :
Long-Term Cost Effectiveness Analysis Of Ideglira Versus Glp-1 Added To Basal Insulin As Intensification Therapies In Type 2 Diabetes Mellitus In Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01782-4&doi=10.1016/j.jval.2016.03.1714
First page :
A99
Section Title :
Research on Methods - Statistical Methods
Open access? :
No
Section Order :
1753